Market Cap

Gongwin Biopharm Holdings Co. Ltd Market Capitalization:

TW$18.45 Billion

TWD as of July 1, 2024

US$566.5 Million

business Gongwin Biopharm Holdings Co. Ltd Company Profile

Gongwin Biopharm Holdings Co. Ltd Main Stock Listing

TWSE: 6617

Market Capitalization History of Gongwin Biopharm Holdings Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Gongwin Biopharm Holdings Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 TW$20.57 B -79.07%
Jan. 1, 2023 TW$98.31 B 21.31%
Jan. 1, 2022 TW$81.04 B 27.75%
Jan. 1, 2021 TW$63.43 B 157.10%
Jan. 1, 2020 TW$24.67 B 13.09%
Jan. 1, 2019 TW$21.82 B -8.76%
Jan. 1, 2018 TW$23.91 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Gongwin Biopharm Holdings Co. Ltd Categories

Taiwan languages Healthcare languages Biotechnology
Taiwan Healthcare Taiwan Biotechnology

Stocks & Indices

Gongwin Biopharm Holdings Co. Ltd has the following listings and related stock indices.


Stock: TWSE: 6617

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.